62 related articles for article (PubMed ID: 3245852)
1. Experimental studies on the endocrine side effects of new aldosterone antagonists.
Nishino Y; Schröder H; el Etreby MF
Arzneimittelforschung; 1988 Dec; 38(12):1800-5. PubMed ID: 3245852
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro.
Weindel K; Lewicka S; Vecsei P
Arzneimittelforschung; 1991 Sep; 41(9):946-9. PubMed ID: 1796922
[TBL] [Abstract][Full Text] [Related]
3. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
[TBL] [Abstract][Full Text] [Related]
4. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
[TBL] [Abstract][Full Text] [Related]
5. SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone.
Cutler GB; Sauer MA; Loriaux DL
J Pharmacol Exp Ther; 1979 Apr; 209(1):144-6. PubMed ID: 430374
[TBL] [Abstract][Full Text] [Related]
6. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
7. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension.
Opoku J; Kalimi M; Agarwal M; Qureshi D
Am J Physiol; 1991 Feb; 260(2 Pt 1):E269-71. PubMed ID: 1996630
[TBL] [Abstract][Full Text] [Related]
9. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Casals-Stenzel J; Buse M; Wambach G; Losert W
Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of mespirenone, a new aldosterone antagonist, in rat and cynomolgus monkey.
Hildebrand M; Krause W; Kühne G; Hoyer GA
Xenobiotica; 1987 May; 17(5):623-34. PubMed ID: 3604266
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.
Nickisch K; Bittler D; Laurent H; Losert W; Casals-Stenzel J; Nishino Y; Schillinger E; Wiechert R
J Med Chem; 1987 Aug; 30(8):1403-9. PubMed ID: 3612688
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
[TBL] [Abstract][Full Text] [Related]
13. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
[TBL] [Abstract][Full Text] [Related]
14. [Direct action of mineralocorticoid antagonists on biosynthesis of aldosterone: comparative activities of several new compounds].
Netchitailo P; Perroteau I; Delarue C; Leboulenger F; Capron MH; Vaudry H
Can J Physiol Pharmacol; 1983 Jan; 61(1):23-8. PubMed ID: 6301660
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
16. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
17. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.
Cook JC; Mullin LS; Frame SR; Biegel LB
Toxicol Appl Pharmacol; 1993 Apr; 119(2):195-204. PubMed ID: 8480329
[TBL] [Abstract][Full Text] [Related]
18. [Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action].
Corvol P; Mahoudeau JA; Valcke JC; Ménard J; Bricaire H
Nouv Presse Med; 1976 Mar; 5(11):691-4. PubMed ID: 177946
[TBL] [Abstract][Full Text] [Related]
19. Regulation of thyroid hormones on the production of testosterone in rats.
Chiao YC; Lee HY; Wang SW; Hwang JJ; Chien CH; Huang SW; Lu CC; Chen JJ; Tsai SC; Wang PS
J Cell Biochem; 1999 Jun; 73(4):554-62. PubMed ID: 10733348
[TBL] [Abstract][Full Text] [Related]
20. In vivo exposure of young adult male rats to methoxychlor reduces serum testosterone levels and ex vivo Leydig cell testosterone formation and cholesterol side-chain cleavage activity.
Murono EP; Derk RC; Akgul Y
Reprod Toxicol; 2006 Feb; 21(2):148-53. PubMed ID: 16226009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
